semaglutide patent expiry europe Ozempic just got much, much cheaper in India. On March 21, Danish company Novo Nordisk's on semaglutide, the active ingredient behind its diabetes and weight-loss drugs Ozempic and Wegovy, expired in Post-Patent GLP-1s: A Win for
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



.png)






















